Komzifti
Payments companies reported to CMS as associated with Komzifti. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Komzifti, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Komzifti
These are the largest totals companies reported as associated with Komzifti. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Penberthy | Charlottesville, VA | Radiation Oncology | $74.24 |
| Aminder Mehdi | Stockton, CA | $30.00 | |
| Nicole Rozario | Tampa, FL | Nurse Practitioner | $29.86 |
| Mayer Fishman | Tampa, FL | Medical Oncology | $29.86 |
| Gurinder Sidhu | Brooklyn, NY | Medical Oncology | $29.22 |
| Daniel Mirda | Napa, CA | Hematology & Oncology | $29.22 |
| Neha Damle | Oakland, CA | Hematology & Oncology | $29.22 |
| Foma Munoh Kenne | Staten Island, NY | Internal Medicine | $28.72 |
| Angela Purvis | Albuquerque, NM | Nurse Practitioner | $28.72 |
| Jennifer O Stasik | Tulsa, OK | Medical Oncology | $27.74 |
Prescribed Komzifti?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.